The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Cytokines, macrophage lipid metabolism and foam cells: Implications for cardiovascular disease therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745
Goldstein, J. L., Ho, Y. K., Basu, S. K., & Brown, M. S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.333 · Cited by 2,448
Interleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
The immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2292 · Cited by 1,707
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
Immune and Inflammatory Mechanisms of Atherosclerosis
Galkina, E., & Ley, K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132620 · Cited by 1,437
Tabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399
Bouhlel, M. A., Derudas, B., Rigamonti, E., Dièvart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.010 · Cited by 1,325
Simons, K., & Ikonen, E. (2000) · Science · doi:10.1126/science.290.5497.1721 · Cited by 1,275
Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1567 · Cited by 1,269
Mann, D. L., McMurray, J. J. V., Packer, M., Swedberg, K., Borer, J. S., Colucci, W. S., Djian, J., Drexler, H., Feldman, A., Kober, L., et al. (2004) · Circulation · doi:10.1161/01.cir.0000124490.27666.b2 · Cited by 1,240
Macrophage death and defective inflammation resolution in atherosclerosis
Tabas, I. (2010) · Nature Reviews Immunology · doi:10.1038/nri2675 · Cited by 1,120
Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Kastelein, J. J., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60447-5 · Cited by 1,010
Frostegård, J., Ulfgren, A.-K., Nyberg, P., Hedin, U., Swedenborg, J., Andersson, U., & Hansson, G. K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00011-8 · Cited by 1,002
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.
Berliner, J. A., Territo, M. C., Sevanian, A., Ramin, S., Kim, J. A., Bamshad, B., Esterson, M., & Fogelman, A. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114562 · Cited by 925
Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
Jain, M. K., & Ridker, P. M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1901 · Cited by 915
Burke, G. L., Evans, G. W., Riley, W. A., Sharrett, A. R., Howard, G., Barnes, R. W., Rosamond, W., Crow, R. S., Rautaharju, P. M., & Heiss, G. (1995) · Stroke · doi:10.1161/01.str.26.3.386 · Cited by 898
Monocytes in atherosclerosis: subsets and functions
Woollard, K. J., & Geissmann, F. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.228 · Cited by 890
Protective Role of Interleukin-10 in Atherosclerosis
Mallat, Z., Besnard, S., Duriez, M., Deleuze, V., Emmanuel, F., Bureau, M. F., Soubrier, F., Esposito, B., Duez, H., Fievet, C., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.8.e17 · Cited by 831
Inflammation in Atherosclerosis: Transition From Theory to Practice
Libby, P., Okamoto, Y., Rocha, V. Z., & Folco, E. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0706 · Cited by 799
Chemokines in the Pathogenesis of Vascular Disease
Charo, I. F., & Taubman, M. B. (2004) · Circulation Research · doi:10.1161/01.res.0000146672.10582.17 · Cited by 752
Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice
Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., Asano, M., Moriwaki, H., & Seishima, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000064374.15232.c3 · Cited by 748
Smith, J. D., Trogan, E., Ginsberg, M., Grigaux, C., Tian, J., & Miyata, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8264 · Cited by 724
The macrophage foam cell as a target for therapeutic intervention
Li, A. C., & Glass, C. K. (2002) · Nature Medicine · doi:10.1038/nm1102-1235 · Cited by 700
Lowering blood cholesterol to prevent heart disease
Hupp, J. R. (1985) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/0278-2391(85)90208-3 · Cited by 644
IL-33 reduces the development of atherosclerosis
Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H., McInnes, I. B., & Liew, F. Y. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071868 · Cited by 642
Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells
Glass, C. K., & Saijo, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2748 · Cited by 619
Cytokines and atherosclerosis: a comprehensive review of studies in mice
Kleemann, R., Zadelaar, S., & Kooistra, T. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn120 · Cited by 606
Consequences of cellular cholesterol accumulation: basic concepts and physiological implications
Tabas, I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16452 · Cited by 598
Scavenger Receptors in Atherosclerosis: Beyond Lipid Uptake
Moore, K. J., & Freeman, M. W. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000229218.97976.43 · Cited by 562
HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis
Tall, A. R., Yvan-Charvet, L., Terasaka, N., Pagler, T., & Wang, N. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.001 · Cited by 540
Consequences of cellular cholesterol accumulation: basic concepts and physiological implications
Tabas, I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216452 · Cited by 540
Jacobsson, L., Turesson, C., Gülfe, A., Kapetanovic, M. C., Petersson, I. F., Saxne, T., & Geborek, P. (2005) · PubMed · Cited by 533
NEWBY, A. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.08.002 · Cited by 529
Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis
Schrijvers, D. M., De Meyer, G. R. Y., Kockx, M. M., Herman, A. G., & Martinet, W. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000166517.18801.a7 · Cited by 509
Llodrá, J., Angeli, V., Liu, J., Trogan, E., Fisher, E. A., & Randolph, G. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403259101 · Cited by 509
Importance of Different Pathways of Cellular Cholesterol Efflux
Yancey, P. G., Bortnick, A. E., Kellner-Weibel, G., de la Llera-Moya, M., Phillips, M. C., & Rothblat, G. H. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000057572.97137.dd · Cited by 507
Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization
Stoll, G., & Bendszus, M. (2006) · Stroke · doi:10.1161/01.str.0000226901.34927.10 · Cited by 503
The role of junctional adhesion molecules in vascular inflammation
Weber, C., Fraemohs, L., & Dejana, E. (2007) · Nature Reviews Immunology · doi:10.1038/nri2096 · Cited by 503
Newby, A. C. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.173898 · Cited by 496
The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis.
Rudijanto, A. (2007) · PubMed · Cited by 495
Interleukin-6 Exacerbates Early Atherosclerosis in Mice
Huber, S. A., Sakkinen, P., Conze, D., Hardin, N., & Tracy, R. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2364 · Cited by 443
Blockade of Interleukin-17A Results in Reduced Atherosclerosis in Apolipoprotein E–Deficient Mice
Smith, E., Prasad, K.-M. R., Butcher, M., Dobrian, A., Kolls, J. K., Ley, K., & Galkina, E. (2010) · Circulation · doi:10.1161/circulationaha.109.924886 · Cited by 421
Eid, R. E., Rao, D. A., Zhou, J., Lo, S.-F. L., Ranjbaran, H., Gallo, A., Sokol, S. I., Pfau, S., Pober, J. S., & Tellides, G. (2009) · Circulation · doi:10.1161/circulationaha.108.827618 · Cited by 412
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis
Taleb, S., Romain, M., Ramkhelawon, B., Uyttenhove, C., Pasterkamp, G., Herbin, O., Esposito, B., Perez, N., Yasukawa, H., Van Snick, J., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090545 · Cited by 408
Effect of ACAT Inhibition on the Progression of Coronary Atherosclerosis
Nissen, S. E., Tuzcu, E. M., Brewer, H. B., Sipahi, I., Nicholls, S. J., Ganz, P., Schoenhagen, P., Waters, D. D., Pepine, C. J., Crowe, T. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054699 · Cited by 398
Chemokines in Atherosclerosis: An Update
Zernecke, A., Shagdarsuren, E., & Weber, C. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.161174 · Cited by 376
Monocyte recruitment and foam cell formation in atherosclerosis
Bobryshev, Y. V. (2006) · Micron · doi:10.1016/j.micron.2005.10.007 · Cited by 374
Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease
Swirski, F. K., Pittet, M. J., Kircher, M. F., Aikawa, E., Jaffer, F. A., Libby, P., & Weissleder, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604260103 · Cited by 367
Newby, A. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00286-7 · Cited by 362
Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice
Erbel, C., Chen, L., Bea, F., Wangler, S., Celik, S., Lasitschka, F., Wang, Y., Böckler, D., Katus, H. A., & Dengler, T. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901126 · Cited by 358
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice
Schönbeck, U., Sukhova, G. K., Shimizu, K., Mach, F., & Libby, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7458 · Cited by 356
Pinderski, L. J., Fischbein, M. P., Subbanagounder, G., Fishbein, M. C., Kubo, N., Cheroutre, H., Curtiss, L. K., Berliner, J. A., & Boisvert, W. A. (2002) · Circulation Research · doi:10.1161/01.res.0000018941.10726.fa · Cited by 356
DeVries-Seimon, T., Li, Y., Yao, P. M., Stone, E., Wang, Y., Davis, R. J., Flavell, R., & Tabas, I. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200502078 · Cited by 351
Inflammation in Atherosclerosis and Implications for Therapy
Paoletti, R., Gotto, A. M., & Hajjar, D. P. (2004) · Circulation · doi:10.1161/01.cir.0000131514.71167.2e · Cited by 349
Nozaki, S., Kashiwagi, H., Yamashita, S., Nakagawa, T., Kostner, B., Tomiyama, Y., Nakata, A., Ishigami, M., Miyagawa, J., & Kameda-Takemura, K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118231 · Cited by 340
Lusis, A. J., Mar, R., & Pajukanta, P. (2004) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.5.061903.175930 · Cited by 338
Macrophage scavenger receptors and host-derived ligands
Plüddemann, A., Neyen, C., & Gordon, S. (2007) · Methods · doi:10.1016/j.ymeth.2007.06.004 · Cited by 327
The Role of Interleukin 12 in the Development of Atherosclerosis in ApoE-Deficient Mice
Lee, T.-S., Yen, H.-C., Pan, C.-C., & Chau, L.-Y. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.734 · Cited by 311
Regulation of Macrophage Functions by PPAR-α, PPAR-γ, and LXRs in Mice and Men
Rigamonti, E., Chinetti-Gbaguidi, G., & Staels, B. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.158998 · Cited by 293
CXC Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-Derived Macrophages
Gleissner, C. A., Shaked, I., Little, K. M., & Ley, K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901368 · Cited by 286
Kruth, H. S., Jones, N. L., Huang, W., Zhao, B., Ishii, I., Chang, J., Combs, C. A., Malide, D., & Zhang, W.-Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407167200 · Cited by 275
Atherosclerosis and Extracellular Matrix
Katsuda, S., & Kaji, T. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.267 · Cited by 270
Geng, Y. J., & Hansson, G. K. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115718 · Cited by 265
Roles of acyl-coenzyme A : cholesterol acyltransferase-1 and -2
Chang, T.-Y., Chang, C. C. Y., Lin, S., Yu, C., Li, B.-L., & Miyazaki, A. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00008 · Cited by 253
Interferon gamma: A master regulator of atherosclerosis
McLaren, J. E., & Ramji, D. P. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.11.003 · Cited by 239
Self-citationThe key role of apolipoprotein E in atherosclerosis
Greenow, K., Pearce, N. J., & Ramji, D. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0631-3 · Cited by 237
Self-citationConsensus conference. Lowering blood cholesterol to prevent heart disease
(1985) · JAMA · doi:10.1001/jama.253.14.2080 · Cited by 234
High-Density Lipoprotein and Coronary Heart Disease
Natarajan, P., Ray, K. K., & Cannon, C. P. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.008 · Cited by 230
Mechanisms for cellular cholesterol transport: Defects and human disease
Ikonen, E. (2006) · Physiological Reviews · doi:10.1152/physrev.00022.2005 · Cited by 229
Goossens, P., Gijbels, M. J. J., Zernecke, A., Eijgelaar, W., Vergouwe, M. N., van der Made, I., Vanderlocht, J., Beckers, L., Buurman, W. A., Daemen, M. J. A. P., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.06.008 · Cited by 225
Tsukano, H., Gotoh, T., Endo, M., Miyata, K., Tazume, H., Kadomatsu, T., Yano, M., Iwawaki, T., Kohno, K., Araki, K., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.206094 · Cited by 211
Steinberg, D. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400003-jlr200 · Cited by 202
Zhang, X., Jin, J., Peng, X., Ramgolam, V. S., & Markovic-Plese, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6988 · Cited by 201
An Update on the Role of Markers of Inflammation in Atherosclerosis
Corrado, E., Rizzo, M., Coppola, G., Fattouch, K., Novo, G., Marturana, I., Ferrara, F., & Novo, S. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.2600 · Cited by 197
Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients
Ascer, E., Bertolami, M. C., Venturinelli, M. L., Buccheri, V., Souza, J., Nicolau, J. C., Ramires, J. A. F., & Serrano, C. V. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.003 · Cited by 194
Hashmi, S., & Zeng, Q. T. (2006) · Coronary Artery Disease · doi:10.1097/01.mca.0000236288.94553.b4 · Cited by 191
IL-33 Reduces Macrophage Foam Cell Formation
McLaren, J. E., Michael, D. R., Salter, R. C., Ashlin, T. G., Calder, C. J., Miller, A. M., Liew, F. Y., & Ramji, D. P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000520 · Cited by 184
Self-citationde Boer, O. J., van der Meer, J. J., Teeling, P., van der Loos, C. M., Idu, M. M., van Maldegem, F., Aten, J., & van der Wal, A. C. (2010) · The Journal of Pathology · doi:10.1002/path.2667 · Cited by 183
Targeted Disruption of the Scavenger Receptor and Chemokine CXCL16 Accelerates Atherosclerosis
Aslanian, A. M., & Charo, I. F. (2006) · Circulation · doi:10.1161/circulationaha.105.540583 · Cited by 177
Schober, A., Bernhagen, J., Thiele, M., Zeiffer, U., Knarren, S., Roller, M., Bucala, R., & Weber, C. (2004) · Circulation · doi:10.1161/01.cir.0000109201.72441.09 · Cited by 171
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies
Klingenberg, R., & Hansson, G. K. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp477 · Cited by 169
Han, J., Hajjar, D. P., Tauras, J. M., Feng, J., Gotto, A. M., & Nicholson, A. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1241 · Cited by 167
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice
van Es, T., van Puijvelde, G. H. M., Ramos, O. H., Segers, F. M. E., Joosten, L. A., van den Berg, W. B., Michon, I. M., de Vos, P., van Berkel, T. J. C., & Kuiper, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.152 · Cited by 163
Khovidhunkit, W., Moser, A. H., Shigenaga, J. K., Grünfeld, C., & Feingold, K. R. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300100-jlr200 · Cited by 162
Interleukin‐10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice
Han, X., Kitamoto, S., Wang, H., & Boisvert, W. A. (2010) · The FASEB Journal · doi:10.1096/fj.09-148155 · Cited by 158
Panousis, C. G., & Zuckerman, S. H. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1565 · Cited by 155
Devlin, C. M., Kuriakose, G., Hirsch, E., & Tabas, I. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092324399 · Cited by 147
Atherosclerotic Plaque Stability—What Determines the Fate of a Plaque?
Halvorsen, B. L., Otterdal, K., Dahl, T. B., Skjelland, M., Gullestad, L. L., Øie, E., & Aukrust, P. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.09.001 · Cited by 146
NONOXIDATIVE MODIFICATIONS OF LIPOPROTEINS IN ATHEROGENESIS
Tabas, I. A. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.123 · Cited by 138
Li, J., Fu, Q., Cui, H., Qu, B., Pan, W. Q., Shen, N., & Bao, C. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30165 · Cited by 136
Fuhrman, B., Koren, L., Volkova, N., Keidar, S., Hayek, T., & Aviram, M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00063-1 · Cited by 133
Tuomisto, T. T., Lumivuori, H., Kansanen, E., Häkkinen, S.-K., Turunen, M. P., van Thienen, J. V., Horrevoets, A. J. G., Levonen, A., & Ylä‐Herttuala, S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn007 · Cited by 133
The role of transforming growth factor-β in atherosclerosis
SINGH, N., & Ramji, D. P. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.002 · Cited by 132
Self-citationTenger, C., Sundborger, A., Jawień, J., & Zhou, X. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000153516.02782.65 · Cited by 130
Rapid screening for delta F508 deletion in cystic fibrosis.
Scheffer, H., Verlind, E., Penninga, D., et al. (1989) · PubMed · Cited by 129
Kiener, P. A., Davis, P. M., Murray, J. L., Youssef, S., Rankin, B. M., & Kowala, M. C. (2001) · International Immunopharmacology · doi:10.1016/s0162-3109(00)00272-1 · Cited by 128
Peroxisome Proliferator-Activated Receptor α Reduces Cholesterol Esterification in Macrophages
Chinetti, G., Lestavel, S., Fruchart, J., Barthelemy-Clavey, V., & Staels, B. (2003) · Circulation Research · doi:10.1161/01.res.0000053386.46813.e9 · Cited by 123
TNFα induces ABCA1 through NF-κB in macrophages and in phagocytes ingesting apoptotic cells
Gerbod-Giannone, M.-C., Li, Y., Holleboom, A. G., Han, S., Hsu, L.-C., Tabas, I. A., & Tall, A. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510345103 · Cited by 120
Kamari, Y., Shaish, A., Shemesh, S. S., Vax, E., Grosskopf, I., Dotan, S., White, M. R., Voronov, E., Dinarello, C. A., Apte, R. N., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.008 · Cited by 118
PPARγ and its ligands: therapeutic implications in cardiovascular disease
Villacorta, L., Schopfer, F. J., Zhang, J., Freeman, B. Α., & Chen, Y. (2009) · Clinical Science · doi:10.1042/cs20080195 · Cited by 118
Keidar, S., Heinrich, R., Kaplan, M., Hayek, T., & Aviram, M. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0901.095547 · Cited by 118
Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages.
Bottalico, L. A., Wager, R. E., Agellon, L. B., Assoian, R. K., & Tabas, I. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54434-3 · Cited by 114
Rosenson, R. S., Hislop, C., McConnell, D. S., Elliott, M., Stasiv, Y., Wang, N., & Waters, D. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60403-7 · Cited by 114
Sequestration of aggregated low-density lipoproteins by macrophages
Kruth, H. S. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00003 · Cited by 111
The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation
Lin, J., Li, M., Wang, Z., He, S., Ma, X., & Li, D. (2009) · Journal of Lipid Research · doi:10.1194/jlr.d000497 · Cited by 110
The pivotal role of lipoprotein lipase in atherosclerosis
Mead, J. R., & Ramji, D. P. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00405-4 · Cited by 107
Self-citationTGF-β1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages
Draude, G., & Lorenz, R. L. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.4.h1042 · Cited by 105
Koga, M., Kai, H., Yasukawa, H., Yamamoto, T., Kawai, Y., Kato, S., Kusaba, K., Kai, M., Egashira, K., Kataoka, Y., et al. (2007) · Circulation Research · doi:10.1161/circresaha.106.147256 · Cited by 102
Rubic, T., & LORENZ, R. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.10.018 · Cited by 102
Chen, M., Li, W., Wang, N., Zhu, Y., & Wang, X. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00016.2006 · Cited by 100
Montero, M. T., Hernández, O., Suárez, Y., Matilla, J., Ferruelo, A. J., Martı́nez-Botas, J., Gómez-Coronado, D., & Lasunción, M. A. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00417-2 · Cited by 97
Cholesterol suppresses cellular TGF-β responsiveness: implications in atherogenesis
Chen, C., Liu, I., Fliesler, S. J., Han, X., Huang, S. S., & Huang, J. S. (2007) · Journal of Cell Science · doi:10.1242/jcs.006916 · Cited by 94
Shimada, K. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0277 · Cited by 94
Interleukin-10 Facilitates Both Cholesterol Uptake and Efflux in Macrophages
Han, X., Kitamoto, S., Lian, Q., & Boisvert, W. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.040899 · Cited by 93
DIETARY FATS AND CORONARY HEART DISEASE: UNFINISHED BUSINESS
AHRENS, E. H. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92827-7 · Cited by 93
Li, N., McLaren, J. E., Michael, D. R., Clement, M., Fielding, C. A., & Ramji, D. P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000993 · Cited by 93
Self-citationAtorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages
Llaverı́as, G., Noé, V., Peñuelas, S., Vázquez‐Carrera, M., Sánchez, R. M., Laguna, J. C., Ciudad, C. J., & Alegret, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.021 · Cited by 90
Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms.
Brand, K., Mackman, N., & Curtiss, L. K. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116425 · Cited by 89
Tousoulis, D., Antoniades, C. A., Bosinakou, E., Kotsopoulou, M., Pitsavos, C. E., Vlachopoulos, C. V., Panagiotakos, D. B., & Stefanadis, C. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.08.037 · Cited by 88
Argmann, C., Diepstraten, C. V. D., Sawyez, C. G., Edwards, J. Y., Hegele, R. A., Wolfe, B. M. J., & Huff, M. W. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1201.099426 · Cited by 86
Halvorsen, B. L., Wæhre, T., Scholz, H., Clausen, O. P., von der Thüsen, J. H., Müller, F., Heimli, H., Tonstad, S., Hall, C., Frøland, S. S., et al. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400324-jlr200 · Cited by 85
Panousis, C. G., Evans, G. F., & Zuckerman, S. H. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31648-5 · Cited by 85
Reverse cholesterol transport: from classical view to new insights.
van der Velde, A. E. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i47.5908 · Cited by 83
The TNF-Like Protein 1A–Death Receptor 3 Pathway Promotes Macrophage Foam Cell Formation In Vitro
McLaren, J. E., Calder, C. J., McSharry, B. P., Sexton, K., Salter, R. C., Singh, N. N., Wilkinson, G. W. G., Wang, E. C. Y., & Ramji, D. P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903782 · Cited by 79
Self-citationRemnant lipoproteins and atherosclerosis
Twickler, T. B., Dallinga‐Thie, G. M., Chapman, M. J., & Cohn, J. S. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0037-x · Cited by 76
Persson, J., Nilsson, J. Å., & Lindholm, M. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-70 · Cited by 76
Nikolai N. Anichkov and his theory of atherosclerosis.
Konstantinov, I. E., Mejevoi, N., & Аничков, Н. М. (2006) · Europe PMC (PubMed Central) · Cited by 75
Gu, Y., Hu, X., Liu, C., Qv, X., & Xu, C.-G. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07161.x · Cited by 74
Low-density lipoprotein concentration in interstitial fluid from human atherosclerotic lesions
Smith, E. B., & Ashall, C. (1983) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(83)90139-x · Cited by 69
Lei, L., Xiong, Y., Chen, J., Yang, J.-B., Wang, Y., Yang, X., Chang, C. C. Y., Song, B., Chang, T., & Li, B.-L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800484-jlr200 · Cited by 67
Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-γ
Panousis, C. G., & Zuckerman, S. H. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32076-9 · Cited by 65
Han, J., Parsons, M., Zhou, X., NICHOLSON, A. C., Gotto, A. M., & Hajjar, D. P. (2004) · Circulation · doi:10.1161/01.cir.0000148368.79202.f1 · Cited by 63
Lovastatin inhibits gene expression of type-I scavenger receptor in THP-1 human macrophages
Umetani, N., Kanayama, Y., Okamura, M., Negoro, N., & Takeda, T. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00098-7 · Cited by 61
Okopień, B., Krysiak, R. G., Kowalski, J., Madej, A., Belowski, D., Zieliński, M., & Herman, Z. S. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000175455.46245.c8 · Cited by 58
Okopień, B., Krysiak, R. G., Kowalski, J., Madej, A., Belowski, D., Zieliński, M., Łabuzek, K., & Herman, Z. S. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.05.009 · Cited by 58
Hsu, H., & Twu, Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003464200 · Cited by 57
Stumpf, C., Petzi, S., Seybold, K., Wasmeier, G. H., Arnold, M. B., Raaz, D., Yılmaz, A., Daniel, W. G., & Garlichs, C. D. (2008) · Clinical Science · doi:10.1042/cs20080042 · Cited by 55
Enhanced Plasma Levels of LIGHT in Unstable Angina
Scholz, H., Sandberg, W. J., Damås, J. K., Smith, C., Andreassen, A. K., Gullestad, L. L., Frøland, S. S., Yndestad, A., Aukrust, P., & Halvorsen, B. L. (2005) · Circulation · doi:10.1161/circulationaha.105.544676 · Cited by 55
Hofnagel, O., Luechtenborg, B., Weißen-Plenz, G., & Robenek, H. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.06.003 · Cited by 54
Bouhlel, M. A., Staels, B., & Chinetti‐Gbaguidi, G. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01892.x · Cited by 51
Singh, N. N., & Ramji, D. P. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000220383.19192.55 · Cited by 48
Self-citationBrown, B. E., Rashid, I., van Reyk, D. M., & Davies, M. J. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05699.x · Cited by 47
Statin Therapy Increases Carotid Plaque Echogenicity in Hypercholesterolemic Patients
Yamagami, H., Sakaguchi, M., Furukado, S., Hoshi, T., Abe, Y., Hougaku, H., Hori, M., & Kitagawa, K. (2008) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2008.01.019 · Cited by 47
Liao, H.-S., Matsumoto, A., Itakura, H., Doi, T., Honda, M., Kodama, T., & Geng, Y. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.8.1872 · Cited by 47
Irvine, S. A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki280 · Cited by 45
Failure of ACAT Inhibition to Retard Atherosclerosis
Fazio, S., & Linton, M. F. (2006) · New England Journal of Medicine · doi:10.1056/nejme068012 · Cited by 43
Nuclear receptors in macrophages: A link between metabolism and inflammation
Szántó, A., & Rőszer, T. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.020 · Cited by 43
Onitiri, A. C., Lewis, B., Bentall, H. H., Jamieson, C., WISHEART, J. D., & Faris, I. (1976) · Atherosclerosis · doi:10.1016/0021-9150(76)90011-3 · Cited by 42
Nachtigal, P., Pospisilova, N., Jamborova, G., Pospěchová, K., Solichová, D., Andrýs, C., Zdansky, P., Mičuda, S., & Semecký, V. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.01.006 · Cited by 42
Chinetti, G., & Staels, B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.01.009 · Cited by 40
Kitahara, M., Kanaki, T., Toyoda, K., Miyakoshi, C., Tanaka, S., Tamaki, T., & Saitō, Y. (1998) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.77.117 · Cited by 36
Xanthoulea, S., Gijbels, M. J., van der Made, I., Mujčić, H., Thelen, M., Vergouwe, M. N., Ambagts, M. H. C., Hofker, M. H., & de Winther, M. P. J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn193 · Cited by 35
Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: a systematic review
Morgan, C., Zappitelli, M., & Gill, P. J. (2009) · Critical Care · doi:10.1186/cc8135 · Cited by 35
Gantman, A., Fuhrman, B., Aviram, M., & Hayek, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.091 · Cited by 34
Mei, C., Chen, Z., Liao, Y., Wang, Y., Peng, H., & Chen, Y. (2007) · Cell Biology International · doi:10.1016/j.cellbi.2007.06.009 · Cited by 34
Llaverías, G., Lacasa, D., Viñals, M., Vázquez‐Carrera, M., Sánchez, R. M., Laguna, J. C., & Alegret, M. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.009 · Cited by 33
Lentiviral vector-mediated siRNA knockdown of SR-PSOX inhibits foam cell formationin vitro1
ZHANG, L., Hou-jia, L., Li, T., Yang, Y., Guo, X., Wu, M., Rui, Y., & Wei, L. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00823.x · Cited by 31
Lindholm, M., & Nilsson, J. Å. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.07.001 · Cited by 28
Li, N., Salter, R. C., & Ramji, D. P. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22976 · Cited by 27
Self-citationPhospholipase A2 inhibitors in atherosclerosis: the race is on
Corson, M. A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60378-0 · Cited by 26
Baccante, G., Mincione, G., Marcantonio, M. C. D., Piccirelli, A., Cuccurullo, F., & Porreca, E. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.150 · Cited by 19
Edgel, K. A., LeBoeuf, R. C., & Oram, J. F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.019 · Cited by 18
Tekin, A., Sezgin, N., Katırçıbaşı, M. T., Tekin, G., Çölkesen, Y., Sezgin, A. T., & Müderrisoğlu, H. (2008) · Coronary Artery Disease · doi:10.1097/mca.0b013e32830d27d2 · Cited by 10
Treatment with atorvastatin alters interleukin‐12 and ‐10 gene expression
Naoumova, R. P., Patel, D., O’Neill, F. H., Thompson, G. R., & Knight, B. L. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01105.x · Cited by 9
Long-term Risk of Cardiovascular Events With Rosiglitazone: A Meta-analysis
Singh, S., Loke, Y. K., & Furberg, C. D. (2007) · JAMA · doi:10.1001/jama.298.10.1189 · Cited by 5
Beyond C-Reactive Protein: Novel Markers of Vascular Inflammation
Heeschen, C. (2006) · Humana Press eBooks · doi:10.1007/978-1-59745-051-5_18 · Cited by 3
Cited by
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
Huang, S. C.-C., Everts, B., Ivanova, Y., O'Sullivan, D., Nascimento, M., Smith, A. M., Beatty, W., Love-Gregory, L., Lam, W. Y., O'Neill, C. M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2956 · Cited by 1,214
Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
Ramji, D. P., & Davies, T. S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.04.003 · Cited by 469
Self-citationMolecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 459
Metadata
- Authors
- McLaren, J. E., Michael, D. R., Ashlin, T. G., & Ramji, D. P.
- Venue
- Progress in Lipid Research
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 50
- Issue
- 4
- Pages
- 331-347
- ISSN
- 0163-7827 (ISSN-L)
- OpenAlex
- W2093327629
- Cited by
- 397
- References
- 180
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.